PALI Palisade Bio, Inc.
Palisade Bio, Inc. (PALI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $303.3K.
Where they traded
Last open-market purchase: July 9, 2026 , by Baltera Robert Jr. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Baltera Robert Jr. | Director | Buy | 25,000 | $1.96 | $48.9K | 461,904 | |
| Baltera Robert Jr. | Director | Buy | 20,000 | $1.99 | $39.8K | 436,904 | |
| Finley John David | CEO, CFO | Sell | 146,798 | $2.07 | $303.3K | 217,555 −40.3% of holding | |
| Jones Mitchell Lawrence | Chief Medical Officer | Sell | 51,880 | $2.05 | $106.5K | 94,009 −35.6% of holding | |
| Baltera Robert Jr. | Director | Buy | 30,000 | $2.03 | $61.0K | 416,904 | |
| Baltera Robert Jr. | Director | Buy | 20,000 | $2.05 | $41.0K | 386,904 | |
| Baltera Robert Jr. | Director | Buy | 10,000 | $1.98 | $19.8K | 366,904 | |
| Baltera Robert Jr. | Director | Buy | 20,000 | $1.98 | $39.6K | 356,904 | |
| Finley John David | CEO, CFO | Sell | 3,896 | $1.75 | $6.8K | 27,353 −12.5% of holding | |
| Jones Mitchell Lawrence | Chief Medical Officer | Sell | 1,989 | $1.75 | $3.5K | 13,263 −13% of holding | |
| Williams Donald Allen | Director | Buy | 5,000 | $1.67 | $8.4K | 10,728 | |
| Williams Donald Allen | Director | Buy | 5,000 | $1.88 | $9.4K | 5,728 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.